Related Experiment Video
Updated: Jul 7, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics
Miriam Marqués1, Amit Kumar, Isabel Cortés
1Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Darwin 3, Cantoblanco, Madrid E-28049, Spain.
Abstract:
Phosphoinositide 3-kinase (PI3K) is an early signaling molecule that regulates cell growth and cell cycle entry. PI3K is activated immediately after growth factor receptor stimulation (at the G(0)/G(1) transition) and again in late G(1). The two ubiquitous PI3K isoforms (p110alpha and p110beta) are essential during embryonic development and are thought to control cell division. Nonetheless, it is presently unknown at which point each is activated during the cell cycle and whether or not they both control S-phase entry. We found that p110alpha was activated first in G(0)/G(1), followed by a minor p110beta activity peak. In late G(1), p110alpha activation preceded that of p110beta, which showed the maximum activity at this time. p110beta activation required Ras activity, whereas p110alpha was first activated by tyrosine kinases and then further induced by active Ras. Interference with p110alpha and -beta activity diminished the activation of downstream effectors with different kinetics, with a selective action of p110alpha in blocking early G(1) events. We show that inhibition of either p110alpha or p110beta reduced cell cycle entry. These results reveal that PI3Kalpha and -beta present distinct activation requirements and kinetics in G(1) phase, with a selective action of PI3Kalpha at the G(0)/G(1) phase transition. Nevertheless, PI3Kalpha and -beta both regulate S-phase entry.
Insights
Phosphoinositide 3-kinase (PI3K) isoforms p110alpha and p110beta regulate cell cycle entry. p110alpha activates early in G(0)/G(1), while p110beta peaks in late G(1), with both controlling S-phase entry.
Area of Science:
- Cell Biology
- Molecular Signaling
Background:
- Phosphoinositide 3-kinase (PI3K) is crucial for cell growth and cycle progression.
- Two PI3K isoforms, p110alpha and p110beta, are vital for embryonic development and cell division.
Purpose of the Study:
- To determine the specific activation timing of PI3K p110alpha and p110beta during the cell cycle.
- To investigate whether both isoforms regulate entry into S-phase.
Main Methods:
- Analysis of PI3K isoform activation kinetics during G(0)/G(1) and late G(1) phases.
- Investigating the upstream activators (tyrosine kinases, Ras) for each isoform.
- Assessing the impact of isoform inhibition on downstream effectors and cell cycle progression.
Main Results:
- p110alpha is activated first in G(0)/G(1), followed by a minor p110beta peak.
- In late G(1), p110alpha activation precedes p110beta, which shows maximum activity.
- p110beta activation requires Ras, while p110alpha is activated by tyrosine kinases and subsequently by Ras.
- Inhibition of either isoform reduced cell cycle entry, with p110alpha selectively affecting early G(1) events.
Conclusions:
- PI3K p110alpha and p110beta exhibit distinct activation requirements and kinetics within the G(1) phase.
- p110alpha plays a selective role in the G(0)/G(1) transition.
- Both PI3K p110alpha and p110beta are essential regulators of S-phase entry.
More Related Videos
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Inhibition of Cdk Activity
Inhibition of CDK Activity
PI3K/mTOR/AKT Signaling Pathway
Positive Regulator Molecules
Positive Regulator Molecules